← Back to All US Stocks

Icon PLC (ICLR) Fundamental Analysis & AI Grade 2026

ICLR Nasdaq Services-Commercial Physical & Biological Research CIK: 0001060955
Recently Updated • Analysis: May 28, 2026 • SEC Data: 2026-05-28

Icon PLC (ICLR) Financial Metrics & Key Ratios

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

ICLR Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

ICLR vs Healthcare Sector: How Icon PLC Compares

How Icon PLC compares to Healthcare sector averages

Net Margin
ICLR 0.0%
vs
Sector Avg 12.0%
ICLR Sector
ROE
ICLR 0.0%
vs
Sector Avg 15.0%
ICLR Sector
Current Ratio
ICLR 0.0x
vs
Sector Avg 2.0x
ICLR Sector
Debt/Equity
ICLR 0.0x
vs
Sector Avg 0.6x
ICLR Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Icon PLC Stock Overvalued? ICLR Valuation Analysis 2026

Based on fundamental analysis, Icon PLC has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Icon PLC Balance Sheet: ICLR Debt, Cash & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

ICLR Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

ICLR SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Icon PLC (CIK: 0001060955)

📋 Recent SEC Filings

Date Form Document Action
May 15, 2026 4 xslF345X06/wk-form4_1778848739.xml View →
May 15, 2026 4 xslF345X06/wk-form4_1778848708.xml View →
May 15, 2026 4 xslF345X06/wk-form4_1778848686.xml View →
May 7, 2021 SC 13G SEC13G_Filing.htm View →
Feb 10, 2017 SC 13G SEC13G_Filing.htm View →

Frequently Asked Questions about ICLR

What is the AI rating for ICLR?

Icon PLC (ICLR) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.

What are ICLR's key strengths?

Claude: Analysis in progress.

What are the risks of investing in ICLR?

Claude: Analysis in progress.

What is ICLR's revenue and growth?

Icon PLC reported revenue of N/A.

Does ICLR pay dividends?

Icon PLC does not currently pay dividends.

Where can I find ICLR SEC filings?

Official SEC filings for Icon PLC (CIK: 0001060955) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is ICLR's EPS?

Icon PLC has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is ICLR's fundamental grade?

Based on our AI fundamental analysis in May 2026, Icon PLC has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is ICLR stock overvalued or undervalued?

Valuation metrics for ICLR: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is ICLR's AI grade for 2026?

Our dual AI analysis gives Icon PLC a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is ICLR's free cash flow?

Icon PLC's operating cash flow is N/A, with capital expenditures of N/A.

How does ICLR compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 28, 2026 | Data as of: 2026-05-28 | Powered by Claude AI